243 related articles for article (PubMed ID: 37352376)
1. Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex.
Nyquist MD; Coleman IM; Lucas JM; Li D; Hanratty B; Meade H; Mostaghel EA; Plymate SR; Corey E; Haffner MC; Nelson PS
Cancer Res; 2023 Sep; 83(17):2938-2951. PubMed ID: 37352376
[TBL] [Abstract][Full Text] [Related]
2. Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation.
Vander Griend DJ; Litvinov IV; Isaacs JT
Int J Biol Sci; 2014; 10(6):627-42. PubMed ID: 24948876
[TBL] [Abstract][Full Text] [Related]
3. Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA damage.
Chatterjee P; Schweizer MT; Lucas JM; Coleman I; Nyquist MD; Frank SB; Tharakan R; Mostaghel E; Luo J; Pritchard CC; Lam HM; Corey E; Antonarakis ES; Denmeade SR; Nelson PS
J Clin Invest; 2019 Jul; 129(10):4245-4260. PubMed ID: 31310591
[TBL] [Abstract][Full Text] [Related]
4. Dissecting transcription of the 8q24-MYC locus in prostate cancer recognizes the equilibration between androgen receptor direct and indirect dual-functions.
Guo J; Wei Z; Jia T; Wang L; Nama N; Liang J; Liao X; Liu X; Gao Y; Liu X; Wang K; Fu B; Chen SS
J Transl Med; 2023 Oct; 21(1):716. PubMed ID: 37828515
[TBL] [Abstract][Full Text] [Related]
5. NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.
Yu C; Wu G; Li R; Gao L; Yang F; Zhao Y; Zhang J; Zhang R; Zhang J; Yao L; Yuan J; Li X
Cancer Biol Ther; 2015; 16(2):287-96. PubMed ID: 25756511
[TBL] [Abstract][Full Text] [Related]
6. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
Dulinska-Litewka J; McCubrey JA; Laidler P
Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor and MYC equilibration centralizes on developmental super-enhancer.
Guo H; Wu Y; Nouri M; Spisak S; Russo JW; Sowalsky AG; Pomerantz MM; Wei Z; Korthauer K; Seo JH; Wang L; Arai S; Freedman ML; He HH; Chen S; Balk SP
Nat Commun; 2021 Dec; 12(1):7308. PubMed ID: 34911936
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC.
Sena LA; Kumar R; Sanin DE; Thompson EA; Rosen DM; Dalrymple SL; Antony L; Yang Y; Gomes-Alexandre C; Hicks JL; Jones T; Bowers KA; Eskra JN; Meyers J; Gupta A; Skaist A; Yegnasubramanian S; Luo J; Brennen WN; Kachhap SK; Antonarakis ES; De Marzo AM; Isaacs JT; Markowski MC; Denmeade SR
J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36194476
[TBL] [Abstract][Full Text] [Related]
9. MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer.
Crowell PD; Giafaglione JM; Jones AE; Nunley NM; Hashimoto T; Delcourt AML; Petcherski A; Agrawal R; Bernard MJ; Diaz JA; Heering KY; Huang RR; Low JY; Matulionis N; Navone NM; Ye H; Zoubeidi A; Christofk HR; Rettig MB; Reiter RE; Haffner MC; Boutros PC; Shirihai OS; Divakaruni AS; Goldstein AS
Cell Rep; 2023 Oct; 42(10):113221. PubMed ID: 37815914
[TBL] [Abstract][Full Text] [Related]
10. Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching.
Li Y; Zhang DY; Ren Q; Ye F; Zhao X; Daniels G; Wu X; Dynlacht B; Lee P
Mol Cell Biol; 2012 Jul; 32(13):2454-66. PubMed ID: 22508987
[TBL] [Abstract][Full Text] [Related]
11. TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.
Siu MK; Chen WY; Tsai HY; Chen HY; Yin JJ; Chen CL; Tsai YC; Liu YN
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):172-178. PubMed ID: 28220803
[TBL] [Abstract][Full Text] [Related]
12. Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA.
Grad JM; Dai JL; Wu S; Burnstein KL
Mol Endocrinol; 1999 Nov; 13(11):1896-911. PubMed ID: 10551783
[TBL] [Abstract][Full Text] [Related]
13. Unique targeting of androgen-dependent and -independent AR signaling in prostate cancer to overcome androgen resistance.
Lim SC; Jansson PJ; Assinder SJ; Maleki S; Richardson DR; Kovacevic Z
FASEB J; 2020 Sep; 34(9):11511-11528. PubMed ID: 32713076
[TBL] [Abstract][Full Text] [Related]
14. NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer.
Nadiminty N; Tummala R; Liu C; Lou W; Evans CP; Gao AC
Mol Cancer Ther; 2015 Aug; 14(8):1884-95. PubMed ID: 26056150
[TBL] [Abstract][Full Text] [Related]
15. Independence of HIF1a and androgen signaling pathways in prostate cancer.
Tran MGB; Bibby BAS; Yang L; Lo F; Warren AY; Shukla D; Osborne M; Hadfield J; Carroll T; Stark R; Scott H; Ramos-Montoya A; Massie C; Maxwell P; West CML; Mills IG; Neal DE
BMC Cancer; 2020 May; 20(1):469. PubMed ID: 32450824
[TBL] [Abstract][Full Text] [Related]
16. Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer.
Denmeade SR; Sena LA; Wang H; Antonarakis ES; Markowski MC
Oncologist; 2023 Jun; 28(6):465-473. PubMed ID: 37027449
[TBL] [Abstract][Full Text] [Related]
17. Androgen action in the prostate gland.
Yadav N; Heemers HV
Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
[TBL] [Abstract][Full Text] [Related]
18. Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth.
Nyquist MD; Ang LS; Corella A; Coleman IM; Meers MP; Christiani AJ; Pierce C; Janssens DH; Meade HE; Bose A; Brady L; Howard T; De Sarkar N; Frank SB; Dumpit RF; Dalton JT; Corey E; Plymate SR; Haffner MC; Mostaghel EA; Nelson PS
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33998604
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor and MYC transcriptomes are equilibrated in multilayer regulatory circuitries in prostate cancer.
Fu B; Wang L; Jia T; Wei Z; Nama N; Liang J; Liao X; Liu X; Gao Y; Liu X; Mao RS; Wang K; Guo J; Chen SS
Prostate; 2023 Nov; 83(15):1415-1429. PubMed ID: 37565264
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin.
Sharma V; Kumar L; Mohanty SK; Maikhuri JP; Rajender S; Gupta G
Mol Cell Endocrinol; 2016 Aug; 431():12-23. PubMed ID: 27132804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
